PTCT

Market-moving news on PTC Therapeutics (NASDAQ: PTCT): filings, earnings, deals and other events, from REDFILED.

PTCT

PTC THERAPEUTICS (PTCT) Closes Sangamo Deal for Fabry Gene Therapy ST-920

PTC Therapeutics has completed its acquisition of ST-920 from Sangamo and expects to finish a rolling BLA submission for accelerated approval in Q4 2026.

PTCT

PTC THERAPEUTICS (PTCT) Director Schmertzler Sells $1.35M in Stock

Board member Michael Schmertzler sold 20,000 PTC Therapeutics shares on 16 and 17 September at prices between $66.58 and $68.45.